Pulsenmore Ltd. Ordinary Shares - Asset Resilience Ratio
Pulsenmore Ltd. Ordinary Shares (PLSM) has an Asset Resilience Ratio of 46.67% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Pulsenmore Ltd. Ordinary Shares's Asset Resilience Ratio has changed over time. See PLSM free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down Pulsenmore Ltd. Ordinary Shares's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Pulsenmore Ltd. Ordinary Shares worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $47.53 Million | 46.67% |
| Total Liquid Assets | $47.53 Million | 46.67% |
Asset Resilience Insights
- Very High Liquidity: Pulsenmore Ltd. Ordinary Shares maintains exceptional liquid asset reserves at 46.67% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Pulsenmore Ltd. Ordinary Shares Industry Peers by Asset Resilience Ratio
Compare Pulsenmore Ltd. Ordinary Shares's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO |
Medical Devices | 10.80% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for Pulsenmore Ltd. Ordinary Shares (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Pulsenmore Ltd. Ordinary Shares.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 46.67% | $47.53 Million | $101.85 Million | +2.35pp |
| 2024-12-31 | 44.32% | $62.71 Million | $141.50 Million | -21.19pp |
| 2023-12-31 | 65.51% | $116.85 Million | $178.37 Million | -5.51pp |
| 2022-12-31 | 71.01% | $164.36 Million | $231.45 Million | +46.80pp |
| 2021-12-31 | 24.21% | $40.45 Million | $167.04 Million | -- |
About Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products. The company was incorporated in 2014 and is based in Omer, Israel.